NCT00528931View on ClinicalTrials.gov

A Pharmacokinetic Study of AA4500 (XIAFLEX™, Proposed Name) in Subjects With Dupuytren's Contracture

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

March 31, 2008

Conditions
Dupuytren's Contracture
Interventions
BIOLOGICAL

collagenase clostridium histolyticum

Single dose of AA4500 0.58 mg into the cord

Trial Locations (1)

91505

Providence Clinical Research, Burbank

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY